Surgical Science climbs 80% since a director's purchase
- Insider
- Thomas Eklund
- Role
- Board member
- Company
- Surgical Science Sweden (SUS)
- Transaction
- Buy
- Shares
- 262,588
- Amount
- SEK 8.3M
- Trade date
- Nov 27, 2025
- Filed
- Nov 28, 2025, 1 day after the trade
- Source
- Finansinspektionen ↗
Director Thomas Eklund bought 262,588 shares of Surgical Science Sweden at SEK 31.78 on Nov 27, 2025, a purchase worth SEK 8.3M. At 09:42 CET on October 28, 2026 the stock traded at SEK 61.00, 92% higher than the price paid.
Measured from the first close after the purchase, SEK 33.96 on Nov 28, 2025, the change is 79.6%. The share first traded 70% or more above that level today.
When the purchase was filed, it was larger than each of the 10 earlier insider purchases of Surgical Science Sweden in our records since 2021. 2 holders had disclosed net short positions before 2025-11-28, together 2.03%. Thomas Eklund has reported no sales since.
SUS +0.9% on the day, close Oct 30
Since purchase+79.6%SEK 33.96 → SEK 61.00 at 09:42 CET
Since filing+77.3%SEK 34.40 on Dec 1 → SEK 61.00
PurchaseSEK 8.3M262,588 shares on Nov 27, 2025
Days since purchase335No sales by this filer since
Price since the purchase
Daily close · SEK+70%
0%
Nov 28 · first close 33.96 SEKOct 28 · 61.00 SEK
PurchaseFirst close above +70%